Global Ophthalmic Drugs Sales Market Report 2016

November 2016 | 121 pages | ID: G713304BCC1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ophthalmic Drugs

Revenue, means the sales value of Ophthalmic Drugs

This report studies sales (consumption) of Ophthalmic Drugs in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novartis
• Santen Pharmaceutical
• Merck
• Roche Holding AG
• Pfizer
• Allergan
• Valeant
• Regeneron
• Bayer
• Senju
• Akorn

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Ophthalmic Drugs in these regions, from 2011 to 2021 (forecast), like

• USA
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Prescription Drugs
• OTC Drugs
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Ophthalmic Drugs in each application, can be divided into

• Dry Eye Drugs
• Retinal Drugs
• Anti-inflammatory/allergy/infective Drugs
• Anti-glaucoma Drugs
• Others

Contents

Global Ophthalmic Drugs Sales Market Report 2016

1 OPHTHALMIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drugs
1.2 Classification of Ophthalmic Drugs
  1.2.1 Prescription Drugs
  1.2.2 OTC Drugs
  1.2.3 Type III
1.3 Application of Ophthalmic Drugs
  1.3.1 Dry Eye Drugs
  1.3.2 Retinal Drugs
  1.3.3 Anti-inflammatory/allergy/infective Drugs
  1.3.4 Anti-glaucoma Drugs
  1.3.5 Others
1.4 Ophthalmic Drugs Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Ophthalmic Drugs (2011-2021)
  1.5.1 Global Ophthalmic Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Ophthalmic Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL OPHTHALMIC DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Ophthalmic Drugs Market Competition by Manufacturers
  2.1.1 Global Ophthalmic Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Ophthalmic Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Ophthalmic Drugs (Volume and Value) by Type
  2.2.1 Global Ophthalmic Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Ophthalmic Drugs (Volume and Value) by Regions
  2.3.1 Global Ophthalmic Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Ophthalmic Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Ophthalmic Drugs (Volume) by Application

3 USA OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 USA Ophthalmic Drugs Sales and Value (2011-2016)
  3.1.1 USA Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  3.1.2 USA Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 USA Ophthalmic Drugs Sales Price Trend (2011-2016)
3.2 USA Ophthalmic Drugs Sales and Market Share by Manufacturers
3.3 USA Ophthalmic Drugs Sales and Market Share by Type
3.4 USA Ophthalmic Drugs Sales and Market Share by Application

4 CHINA OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Ophthalmic Drugs Sales and Value (2011-2016)
  4.1.1 China Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Ophthalmic Drugs Sales Price Trend (2011-2016)
4.2 China Ophthalmic Drugs Sales and Market Share by Manufacturers
4.3 China Ophthalmic Drugs Sales and Market Share by Type
4.4 China Ophthalmic Drugs Sales and Market Share by Application

5 EUROPE OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Ophthalmic Drugs Sales and Value (2011-2016)
  5.1.1 Europe Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Ophthalmic Drugs Sales Price Trend (2011-2016)
5.2 Europe Ophthalmic Drugs Sales and Market Share by Manufacturers
5.3 Europe Ophthalmic Drugs Sales and Market Share by Type
5.4 Europe Ophthalmic Drugs Sales and Market Share by Application

6 JAPAN OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Ophthalmic Drugs Sales and Value (2011-2016)
  6.1.1 Japan Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Ophthalmic Drugs Sales Price Trend (2011-2016)
6.2 Japan Ophthalmic Drugs Sales and Market Share by Manufacturers
6.3 Japan Ophthalmic Drugs Sales and Market Share by Type
6.4 Japan Ophthalmic Drugs Sales and Market Share by Application

7 INDIA OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Ophthalmic Drugs Sales and Value (2011-2016)
  7.1.1 India Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  7.1.2 India Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  7.1.3 India Ophthalmic Drugs Sales Price Trend (2011-2016)
7.2 India Ophthalmic Drugs Sales and Market Share by Manufacturers
7.3 India Ophthalmic Drugs Sales and Market Share by Type
7.4 India Ophthalmic Drugs Sales and Market Share by Application

8 SOUTHEAST ASIA OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Ophthalmic Drugs Sales and Value (2011-2016)
  8.1.1 Southeast Asia Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Ophthalmic Drugs Sales Price Trend (2011-2016)
8.2 Southeast Asia Ophthalmic Drugs Sales and Market Share by Manufacturers
8.3 Southeast Asia Ophthalmic Drugs Sales and Market Share by Type
8.4 Southeast Asia Ophthalmic Drugs Sales and Market Share by Application

9 GLOBAL OPHTHALMIC DRUGS MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Ophthalmic Drugs Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Santen Pharmaceutical
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 121 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Merck
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 145 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 Roche Holding AG
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Oct Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Pfizer
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Allergan
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Valeant
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharma & Healthcare Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Regeneron
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Bayer
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Senju
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Akorn

10 OPHTHALMIC DRUGS MAUFACTURING COST ANALYSIS

10.1 Ophthalmic Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Ophthalmic Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Ophthalmic Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL OPHTHALMIC DRUGS MARKET FORECAST (2016-2021)

14.1 Global Ophthalmic Drugs Sales, Revenue Forecast (2016-2021)
14.2 Global Ophthalmic Drugs Sales Forecast by Regions (2016-2021)
14.3 Global Ophthalmic Drugs Sales Forecast by Type (2016-2021)
14.4 Global Ophthalmic Drugs Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmic Drugs
Table Classification of Ophthalmic Drugs
Figure Global Sales Market Share of Ophthalmic Drugs by Type in 2015
Figure Prescription Drugs Picture
Figure OTC Drugs Picture
Table Applications of Ophthalmic Drugs
Figure Global Sales Market Share of Ophthalmic Drugs by Application in 2015
Figure Dry Eye Drugs Examples
Figure Retinal Drugs Examples
Figure Anti-inflammatory/allergy/infective Drugs Examples
Figure Anti-glaucoma Drugs Examples
Figure Others Examples
Figure USA Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure China Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure India Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Global Ophthalmic Drugs Sales and Growth Rate (2011-2021)
Figure Global Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Table Global Ophthalmic Drugs Sales of Key Manufacturers (2011-2016)
Table Global Ophthalmic Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Ophthalmic Drugs Sales Share by Manufacturers
Figure 2016 Ophthalmic Drugs Sales Share by Manufacturers
Table Global Ophthalmic Drugs Revenue by Manufacturers (2011-2016)
Table Global Ophthalmic Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Ophthalmic Drugs Revenue Share by Manufacturers
Table 2016 Global Ophthalmic Drugs Revenue Share by Manufacturers
Table Global Ophthalmic Drugs Sales and Market Share by Type (2011-2016)
Table Global Ophthalmic Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Ophthalmic Drugs by Type (2011-2016)
Figure Global Ophthalmic Drugs Sales Growth Rate by Type (2011-2016)
Table Global Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)
Table Global Ophthalmic Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ophthalmic Drugs by Type (2011-2016)
Figure Global Ophthalmic Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Ophthalmic Drugs Sales and Market Share by Regions (2011-2016)
Table Global Ophthalmic Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Ophthalmic Drugs by Regions (2011-2016)
Figure Global Ophthalmic Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Ophthalmic Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Ophthalmic Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Ophthalmic Drugs by Regions (2011-2016)
Figure Global Ophthalmic Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Ophthalmic Drugs Sales and Market Share by Application (2011-2016)
Table Global Ophthalmic Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Ophthalmic Drugs by Application (2011-2016)
Figure Global Ophthalmic Drugs Sales Growth Rate by Application (2011-2016)
Figure USA Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure USA Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure USA Ophthalmic Drugs Sales Price Trend (2011-2016)
Table USA Ophthalmic Drugs Sales by Manufacturers (2011-2016)
Table USA Ophthalmic Drugs Market Share by Manufacturers (2011-2016)
Table USA Ophthalmic Drugs Sales by Type (2011-2016)
Table USA Ophthalmic Drugs Market Share by Type (2011-2016)
Table USA Ophthalmic Drugs Sales by Application (2011-2016)
Table USA Ophthalmic Drugs Market Share by Application (2011-2016)
Figure China Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure China Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure China Ophthalmic Drugs Sales Price Trend (2011-2016)
Table China Ophthalmic Drugs Sales by Manufacturers (2011-2016)
Table China Ophthalmic Drugs Market Share by Manufacturers (2011-2016)
Table China Ophthalmic Drugs Sales by Type (2011-2016)
Table China Ophthalmic Drugs Market Share by Type (2011-2016)
Table China Ophthalmic Drugs Sales by Application (2011-2016)
Table China Ophthalmic Drugs Market Share by Application (2011-2016)
Figure Europe Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Europe Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Europe Ophthalmic Drugs Sales by Manufacturers (2011-2016)
Table Europe Ophthalmic Drugs Market Share by Manufacturers (2011-2016)
Table Europe Ophthalmic Drugs Sales by Type (2011-2016)
Table Europe Ophthalmic Drugs Market Share by Type (2011-2016)
Table Europe Ophthalmic Drugs Sales by Application (2011-2016)
Table Europe Ophthalmic Drugs Market Share by Application (2011-2016)
Figure Japan Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Japan Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Japan Ophthalmic Drugs Sales by Manufacturers (2011-2016)
Table Japan Ophthalmic Drugs Market Share by Manufacturers (2011-2016)
Table Japan Ophthalmic Drugs Sales by Type (2011-2016)
Table Japan Ophthalmic Drugs Market Share by Type (2011-2016)
Table Japan Ophthalmic Drugs Sales by Application (2011-2016)
Table Japan Ophthalmic Drugs Market Share by Application (2011-2016)
Figure India Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure India Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure India Ophthalmic Drugs Sales Price Trend (2011-2016)
Table India Ophthalmic Drugs Sales by Manufacturers (2011-2016)
Table India Ophthalmic Drugs Market Share by Manufacturers (2011-2016)
Table India Ophthalmic Drugs Sales by Type (2011-2016)
Table India Ophthalmic Drugs Market Share by Type (2011-2016)
Table India Ophthalmic Drugs Sales by Application (2011-2016)
Table India Ophthalmic Drugs Market Share by Application (2011-2016)
Figure Southeast Asia Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Southeast Asia Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Southeast Asia Ophthalmic Drugs Sales by Manufacturers (2011-2016)
Table Southeast Asia Ophthalmic Drugs Market Share by Manufacturers (2011-2016)
Table Southeast Asia Ophthalmic Drugs Sales by Type (2011-2016)
Table Southeast Asia Ophthalmic Drugs Market Share by Type (2011-2016)
Table Southeast Asia Ophthalmic Drugs Sales by Application (2011-2016)
Table Southeast Asia Ophthalmic Drugs Market Share by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Ophthalmic Drugs Global Market Share (2011-2016)
Table Santen Pharmaceutical Basic Information List
Table Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Santen Pharmaceutical Ophthalmic Drugs Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Ophthalmic Drugs Global Market Share (2011-2016)
Table Roche Holding AG Basic Information List
Table Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Holding AG Ophthalmic Drugs Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Ophthalmic Drugs Global Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Ophthalmic Drugs Global Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Valeant Ophthalmic Drugs Global Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Regeneron Ophthalmic Drugs Global Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Ophthalmic Drugs Global Market Share (2011-2016)
Table Senju Basic Information List
Table Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Senju Ophthalmic Drugs Global Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Akorn Ophthalmic Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Drugs
Figure Ophthalmic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
Table Major Buyers of Ophthalmic Drugs
Table Distributors/Traders List
Figure Global Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Ophthalmic Drugs Sales Forecast by Regions (2016-2021)
Table Global Ophthalmic Drugs Sales Forecast by Type (2016-2021)
Table Global Ophthalmic Drugs Sales Forecast by Application (2016-2021)